Literature DB >> 8172209

Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis.

T F Parker1, L Husni, W Huang, N Lew, E G Lowrie.   

Abstract

The mortality rate for hemodialysis patients in the United States is higher than in other industrialized countries. Some attribute this to insufficient quantities of prescribed and delivered dialysis. A multicenter study in Dallas dialysis centers (Dallas Nephrology Associates) was begun in 1989 to assess the impact of increasing the delivered quantity of dialysis on mortality in subsequent years. Dialysis dose was measured by urea kinetic modeling. Kt/V, reflecting the fractional volume of body water clearance of urea during a dialysis treatment, was purposefully increased from 1.18 starting in 1989 to 1.46 in 1992. Additionally, the dialysis dose measured by the urea reduction ratio, the fractional reduction of blood urea nitrogen concentration caused by a dialysis treatment, increased from 63.0% to 69.6% between 1990 and 1992. Outcome analytical methods included both crude and standardized mortality rates and mortality ratios standardized to large end-stage renal disease databases at the United States Renal Data System and at National Medical Care, Inc. Crude mortality rates at Dallas Nephrology Associates decreased from 22.5% in 1989 to 18.1% in 1992. In comparison, between 1990 and 1992 the urea reduction ration in National Medical Care facilities increased from 57.1% to 62.5%. During that time crude mortality rates decreased from 21.8% to 19.5%. Crude mortality in the United States remained essentially unchanged in the same time period. By 1992, Dallas Nephrology Associates and National Medical Care had standardized mortality ratios of 0.77 and 0.74, respectively, compared with the US dialysis population, indicating almost 30% fewer observed deaths than expected. Monitoring dialysis dose by urea kinetic modeling or urea reduction ratio are equally effective in predicting improvement in patient survival. Improved survival is possible in the US end-stage renal disease program with greater amounts of dialysis. This strategy can save an estimated 8,000 to 16,000 lives per year.

Entities:  

Mesh:

Year:  1994        PMID: 8172209     DOI: 10.1016/s0272-6386(12)70277-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

1.  On-line monitoring of solutes in dialysate using wavelength-dependent absorption of ultraviolet radiation.

Authors:  I Fridolin; L G Lindberg
Journal:  Med Biol Eng Comput       Date:  2003-05       Impact factor: 2.602

2.  Body composition monitoring-derived urea distribution volume in children on chronic hemodialysis.

Authors:  Ariane Zaloszyc; Michel Fischbach; Betti Schaefer; Lorenz Uhlmann; Rémi Salomon; Saoussen Krid; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2016-01-11       Impact factor: 3.714

3.  Impact of residual kidney function on hemodialysis adequacy and patient survival.

Authors:  Mengjing Wang; Yoshitsugu Obi; Elani Streja; Connie M Rhee; Jing Chen; Chuanming Hao; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

Review 4.  Chronic Hemodialysis Therapy in the West.

Authors:  Michael V Rocco
Journal:  Kidney Dis (Basel)       Date:  2015-11-18

5.  Dose of hemodialysis and survival: a marginal structural model analysis.

Authors:  Paungpaga Lertdumrongluk; Elani Streja; Connie M Rhee; Jongha Park; Onyebuchi A Arah; Steven M Brunelli; Allen R Nissenson; Daniel Gillen; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2014-04-26       Impact factor: 3.754

6.  Adequacy of haemodialysis and or haemofiltration treatments for patients with acute kidney injury.

Authors:  Andrew Davenport
Journal:  F1000 Med Rep       Date:  2010-05-11

7.  Balancing the Evidence: How to Reconcile the Results of Observational Studies vs. Randomized Clinical Trials in Dialysis.

Authors:  Jenny I Shen; Erik L Lum; Tara I Chang
Journal:  Semin Dial       Date:  2016-05-21       Impact factor: 3.455

8.  Nephrologist caseload and hemodialysis patient survival in an urban cohort.

Authors:  Kevin T Harley; Elani Streja; Connie M Rhee; Miklos Z Molnar; Csaba P Kovesdy; Alpesh N Amin; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 10.121

9.  In vivo validation of the adequacy calculator for continuous renal replacement therapies.

Authors:  Zaccaria Ricci; Gabriella Salvatori; Monica Bonello; Tirak Pisitkun; Irene Bolgan; Giuseppe D'Amico; Maurizio Dan; Pasquale Piccinni; Claudio Ronco
Journal:  Crit Care       Date:  2005-04-07       Impact factor: 9.097

Review 10.  Intensity of continuous renal replacement therapy for acute kidney injury.

Authors:  Alicia I Fayad; Daniel G Buamscha; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.